Stephan Skawran
Overview
Explore the profile of Stephan Skawran including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
129
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fischer A, Martinez-Gomez J, Mangana J, Dummer R, Erlic Z, Nolting S, et al.
Clin Nucl Med
. 2024 Sep;
49(12):e656-e663.
PMID: 39325145
Purpose: Hypophysitis occurs in up to 10% of patients treated with immune-checkpoint inhibitors (ICIs). MRI shows no abnormalities of the pituitary gland in one third of patients. A delayed diagnosis...
2.
Moser N, Skawran S, Steigmiller K, Rohrnbauer B, Winklehner T, Reiner C, et al.
Diagnostics (Basel)
. 2024 May;
14(9).
PMID: 38732338
Background: The levator ani muscle (LAM) is crucial for pelvic floor stability, yet its quantitative MRI assessment is only a recent focus. Our study aims to standardize the quantitative analysis...
3.
Popescu C, Zhang B, Sartoretti T, Spielhofer N, Skawran S, Heimer J, et al.
EJNMMI Res
. 2024 Apr;
14(1):36.
PMID: 38578516
Background: Liver uptake in [Ga]Ga-PSMA-11 PET is used as an internal reference in addition to clinical parameters to select patients for [Lu]Lu-PSMA-617 radioligand therapy (RLT). Due to increased demand, [Ga]Ga-PSMA-11...
4.
Gennari A, Rossi A, Sartoretti T, Maurer A, Skawran S, Treyer V, et al.
Sci Rep
. 2023 Oct;
13(1):18357.
PMID: 37884535
This study aimed to evaluate the diagnostic accuracy of Node Reporting and Data System (Node-RADS) in discriminating between normal, reactive, and metastatic axillary LNs in patients with melanoma who underwent...
5.
Waelti S, Skawran S, Sartoretti T, Schwyzer M, Gennari A, Mader C, et al.
Eur Radiol
. 2023 Oct;
34(5):3252-3259.
PMID: 37855853
Objectives: To assess the evolution of administered radiotracer activity for F-18-fluorodeoxyglucose (18F-FDG) PET/CT or PET/MR in pediatric patients (0-16 years) between years 2000 and 2021. Methods: Pediatric patients (≤ 16...
6.
Skawran S, Sartoretti T, Gennari A, Schwyzer M, Sartoretti E, Treyer V, et al.
Br J Radiol
. 2023 Sep;
96(1152):20220482.
PMID: 37751216
Objectives: To evaluate the evolution of CT radiation dose in pediatric patients undergoing hybrid 2-[F]fluoro-2-deoxy-D-glucose (2-[F]FDG) PET/CT between 2007 and 2021. Methods And Materials: Data from all pediatric patients aged...
7.
Sartoretti T, Skawran S, Gennari A, Maurer A, Euler A, Treyer V, et al.
Eur Radiol
. 2023 Aug;
34(3):1716-1723.
PMID: 37644149
Objectives: To introduce an automated computational algorithm that estimates the global noise level across the whole imaging volume of PET datasets. Methods: [F]FDG PET images of 38 patients were reconstructed...
8.
Schwyzer M, Skawran S, Gennari A, Waelti S, Walter J, Curioni-Fontecedro A, et al.
Sci Rep
. 2023 Jul;
13(1):11332.
PMID: 37443158
To evaluate whether a machine learning classifier can evaluate image quality of maximum intensity projection (MIP) images from F18-FDG-PET scans. A total of 400 MIP images from F18-FDG-PET with simulated...
9.
Skawran S, Schiesser H, Maurer A, Sartoretti T, Dittli M, Mader C, et al.
Vaccine
. 2022 Nov;
40(52):7640-7645.
PMID: 36372666
Purpose: To evaluate the temporal evolution of vaccination against COVID-19 in a Swiss oncological cohort. Methods: History of complete vaccination (i.e. at least two vaccine doses) against COVID-19 of patients...
10.
Sartoretti E, Gennari A, Maurer A, Sartoretti T, Skawran S, Schwyzer M, et al.
Sci Rep
. 2022 Nov;
12(1):19191.
PMID: 36357446
Our aim was to identify and quantify high coronary artery calcium (CAC) with deep learning (DL)-powered CAC scoring (CACS) in oncological patients with known very high CAC (≥ 1000) undergoing...